Previous 10 | Next 10 |
2023-07-12 14:09:52 ET Summary Seer sells an integrated proteomics analysis system to biopharma firms and academic researchers. The firm's revenue growth is high from a small base and it is generating high and worsening operating losses. With sales cycles lengthening, I'm Neut...
2023-06-22 17:31:01 ET Gainers: Trupanion ( TRUP ) +15% . Stronghold Digital Mining ( SDIG ) +6% . Pinduoduo ( PDD ) +6% . CareMax ( CMAX ) +5% . Seer ( SEER ) +4% . Losers: Kinnate Biopharma ( KNTE ) -5% . Ca...
2023-06-16 20:05:22 ET Crude oil exports out of Iran have surged to five-year highs despite U.S. sanctions, signaling something of a resurgence for the country on the world stage but also sapping confidence in an oil market already weakened by lackluster global economic growth and cheap...
REDWOOD CITY, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- Seer, Inc . (NASDAQ: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced an expanded collaboration with Thermo Fisher Scientific, a world leader in serving science, to enab...
REDWOOD CITY, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced the launch of the Proteograph XT Assay Kit , the latest proteomics assay workflow for the Proteograph Product Sui...
2023-05-09 16:47:48 ET Seer press release ( NASDAQ: SEER ): Q1 GAAP EPS of -$0.38 beats by $0.01 . Revenue of $4.05M (+22.4% Y/Y) beats by $0.13M . Seer continues to expect full year 2023 revenue to be in the range of $23 million to $25 million vs $23.95M conse...
Grew revenue 22% year-over-year with continued growth in installed base and an increasing number of customer presentations and publications REDWOOD CITY, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new pl...
REDWOOD CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the first quarter of 2023 after market close on Tuesday, May 9, 2023. Com...
REDWOOD CITY, Calif., March 29, 2023 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced a new scientific publication in PLOS One demonstrating the unmatched utility of the Proteograph Product Suit...
Gainers: Altamira Therapeutics ( CYTO ) +86% . Bullfrog AI ( BFRG ) +26% . Seer ( SEER ) +25% . Ardelyx ( ARDX ) +23% . Lucy Scientific Discovery ( LSDI ) +16% . Losers: Praxis Precision Medicines ( PRAX ) -55% . Veru (...
News, Short Squeeze, Breakout and More Instantly...
REDWOOD CITY, Calif., July 18, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the second quarter 2024 on Thursday, August 8, 2024. Company manag...
Secretome profiles from SpaceX Inspiration4 mission show alterations in oxidative stress, brain homeostasis, and coagulation Creation of first-of-its-kind comprehensive atlas of molecular and physiological multiomic profiles available from multiple spaceflight missions REDWOOD CIT...
REDWOOD CITY, Calif., June 02, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, announced today that PrognomiQ has completed the largest and deepest unbiased mass spectrometry plasma biomarker study to da...